Abbott, in the third year marking its substantial Diversity in Clinical Trials campaign, has introduced ‘Advancing Diversity in Clinical Trials,’ a publication offering strategies to enhance diversity within clinical research teams throughout the United States. At the same time, Abbott […]
Verge Genomics, at the forefront of using artificial intelligence (AI) and human-centric data to revolutionize drug discovery and development, has shared news that Eli Lilly & Company (Lilly) has chosen to move forward with developing treatments targeting two validated drug
Verge Genomics Marks Collaboration Milestones with Eli Lilly for New ALS Treatments Read More »
Samsung Biologics, a renowned contract development and manufacturing organization (CDMO), has recently forged a series of manufacturing agreements with a pharmaceutical company based in Europe. These newly revealed contracts, valued at over $668 million in total, are set to extend
Merck, recognized as MSD outside the United States and Canada, has announced encouraging topline outcomes from the pivotal phase 3 MK-3475A-D77 study. This investigation is analyzing whether the subcutaneous delivery of pembrolizumab—a renowned anti-PD-1 therapy by Merck, commercially known as
Pfizer Inc. has revealed that the European Commission (EC) has authorized the market release of Hympavzi (marstacimab) for the routine prevention of bleeding episodes in individuals aged 12 and older, who weigh at least 35 kg, with severe hemophilia A
In an important step to strengthen economic ties between India and Russia, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) and Russia’s largest bank, Sberbank, are in discussions to establish payment methods in Rupee-Ruble bilateral trade. These discussions aim to
The Indian Ayush Ministry’s partnerships with prestigious institutions such as the Indian Council of Medical Research (ICMR) aim to bolster the scientific grounds of Ayush treatments and facilitate their global recognition. Each initiative under these collaborations is crafted to enhance
The Pharmaceuticals Department (DoP) has turned down Abbott Healthcare’s appeal against the pricing cap set by the National Pharmaceutical Pricing Authority (NPPA) for high blood pressure medication metoprolol in its modified release tablet form. This decision follows multiple denials by
Department of Pharmaceuticals Denies Abbott’s Appeal Against BP Drug Metoprolol Pricing Read More »
The Karnataka government is making significant strides to enhance its information technology and biotechnology sectors by leveraging the region’s workforce and infrastructure assets. To drive this vision forward, three dedicated global innovation hubs will be developed in Bengaluru, Mysuru, and
The pharmaceutical industry must prioritize enhancing risk management to bolster safety and sustainability, asserts Kim Carlson Altom, Global Operations Risk Management Practice Director at dss+. She emphasizes the critical role of leadership in fostering a safety-conscious organizational culture. “Risk management